Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manoj S

Showing results (101-110 of 135) with videos related to

Pageof 14
Sort By:
Nature Communications|July 4, 2025
Optimizing a human monoclonal antibody for better neutralization of SARS-CoV-2Qian Wang, Yicheng Guo, Ryan G Casner, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2020
A simplified cell-based assay to identify coronavirus 3CL protease inhibitorsSamuel J Resnick, Sho Iketani, Seo Jung Hong, et al.
Emerging Microbes & Infections|November 27, 2021
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecovirusesPengfei Wang, Ryan G Casner, Manoj S Nair, et al.
Biorxiv : the Preprint Server for Biology|October 21, 2021
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecovirusesPengfei Wang, Ryan G Casner, Manoj S Nair, et al.
Emerging Microbes & Infections|September 15, 2020
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe diseasePengfei Wang, Lihong Liu, Manoj S Nair, et al.
JACC. Advances|August 29, 2025
An Educational Curriculum for Residents, Advanced Practice Providers, and Fellows in Cardiac Intensive Care UnitsAnthony P Carnicelli, Balimkiz C Senman, P Elliott Miller, et al.
Nature|October 23, 2023
Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spikeQian Wang, Yicheng Guo, Liyuan Liu, et al.
Journal of Virology|April 29, 2021
Inhibitors of Coronavirus 3CL Proteases Protect Cells from Protease-Mediated CytotoxicitySamuel J Resnick, Sho Iketani, Seo Jung Hong, et al.
Science Translational Medicine|May 24, 2023
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivoClare Burn Aschner, Krithika Muthuraman, Iga Kucharska, et al.
Nature|July 5, 2022
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5Qian Wang, Yicheng Guo, Sho Iketani, et al.
Pageof 14

Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
Nature Communications|July 4, 2025
Optimizing a human monoclonal antibody for better neutralization of SARS-CoV-2Qian Wang, Yicheng Guo, Ryan G Casner, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2020
A simplified cell-based assay to identify coronavirus 3CL protease inhibitorsSamuel J Resnick, Sho Iketani, Seo Jung Hong, et al.
Emerging Microbes & Infections|November 27, 2021
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecovirusesPengfei Wang, Ryan G Casner, Manoj S Nair, et al.
Biorxiv : the Preprint Server for Biology|October 21, 2021
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecovirusesPengfei Wang, Ryan G Casner, Manoj S Nair, et al.
Emerging Microbes & Infections|September 15, 2020
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe diseasePengfei Wang, Lihong Liu, Manoj S Nair, et al.
JACC. Advances|August 29, 2025
An Educational Curriculum for Residents, Advanced Practice Providers, and Fellows in Cardiac Intensive Care UnitsAnthony P Carnicelli, Balimkiz C Senman, P Elliott Miller, et al.
Nature|October 23, 2023
Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spikeQian Wang, Yicheng Guo, Liyuan Liu, et al.
Journal of Virology|April 29, 2021
Inhibitors of Coronavirus 3CL Proteases Protect Cells from Protease-Mediated CytotoxicitySamuel J Resnick, Sho Iketani, Seo Jung Hong, et al.
Science Translational Medicine|May 24, 2023
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivoClare Burn Aschner, Krithika Muthuraman, Iga Kucharska, et al.
Nature|July 5, 2022
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5Qian Wang, Yicheng Guo, Sho Iketani, et al.
Pageof 14